Pharma Vital
⚠️ Moderate Risk
FEI: 3004554313 • Plaza Panama, Provincia de Panama • PANAMA
FEI Number
3004554313
Location
Plaza Panama, Provincia de Panama
Country
PANAMAAddress
Urb Marbella Edif Royal Cenber Pb Local, , Plaza Panama, Provincia de Panama, Panama
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 60QDK46PROCAINE HCL (ANESTHETIC) | 472NO ENGLISH | Florida District Office (FLA-DO) |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 54CEL23L-CARNITINE (PROTEIN) | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 53LD99OTHER SKIN CARE PREPARATIONS, N.E.C. | Florida District Office (FLA-DO) | |
| 12/6/2004 | 54CEL23L-CARNITINE (PROTEIN) | Florida District Office (FLA-DO) | |
| 12/6/2004 | 79KGMSILICONE, LIQUID, INJECTABLE | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 12/6/2004 | 66VDK99MISCELLANEOUS PATENT MEDICINES, ETC. | 16DIRECTIONS | Florida District Office (FLA-DO) |
Frequently Asked Questions
What is Pharma Vital's FDA import refusal history?
Pharma Vital (FEI: 3004554313) has 14 FDA import refusal record(s) in our database, spanning from 12/6/2004 to 12/6/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Pharma Vital's FEI number is 3004554313.
What types of violations has Pharma Vital received?
Pharma Vital has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Pharma Vital come from?
All FDA import refusal data for Pharma Vital is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.